Difference between revisions of "Team:NCTU Formosa"

 
(269 intermediate revisions by 9 users not shown)
Line 2: Line 2:
 
<html>
 
<html>
 
<head>
 
<head>
−
<link href='https://2015.igem.org/Team:NCTU_Formosa/wiki_reset?action=raw&ctype=text/css' rel="stylesheet">
+
<link href="https://2015.igem.org/Team:NCTU_Formosa/wiki_reset?action=raw&ctype=text/css" rel="stylesheet">
−
<style type="text/css">
+
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
−
body {
+
<script>
−
color:#fff;
+
$(document).ready(function(){
−
margin:0;
+
 
−
padding:0;
+
    if($(".div3").innerHeight()<$(".div3-1").innerHeight()){
−
background:#3a4044;
+
        $(".div3").css("height",$(".div3-3").innerHeight());
−
}
+
       
−
+
    };
−
.content {
+
−
color:#FFFFFF;
+
−
}
+
  
−
</style>
+
});
 +
</script>
 +
<style>
 +
        body{
 +
padding: 0;
 +
margin: 0;
 +
}
 +
.div1{
 +
        background:rgb(42,189,243);
 +
        height:100vh;
 +
        position:relative;
 +
        width:100%;
 +
}
  
−
</head>
+
        .div2{
 +
        background:#fff;
 +
height:100vh;
 +
        width:100%;
 +
        position:relative;
 +
       
 +
}
 +
        .div3{
 +
        background:#fff;
 +
        width:100%;
 +
height:100vh;
 +
        position:relative;
 +
       
 +
}
 +
.div3-1{
 +
        background:#fff;
 +
        width:28%;
 +
height:18vw;
 +
        position:absolute;
 +
        left:8%;
 +
top:0vh;
 +
        margin-left:0;
 +
}
 +
        .div3-2{
 +
        background:#fff;
 +
        width:28%;
 +
height:18vw;
 +
 +
position:absolute;
 +
        left:36%;
 +
top:0vh;
 +
        margin-left:0;
 +
}
 +
        .div3-3{
 +
        background:#fff;
 +
        width:28%;
 +
height:18vw;
 +
 +
position:absolute;
 +
        left:64%;
 +
top:0vh;
 +
        margin-left:0;
 +
}
 +
        .div4{
 +
        background:#FCFCDE;
 +
        height:80%;
 +
width:100%;
 +
        position:relative;
 +
        top:0vh;
 +
margin-left:0;
 +
}
  
−
<body>
+
/*圖案*/
−
<div style="text-align:center;">
+
−
<div style="margin:0 auto; width:100%; height:100%; line-height:50%;">
+
−
<img src=https://static.igem.org/mediawiki/2015/3/3b/NCTU_Formosa_Homepage_mark.png></div></div>
+
−
<div class="content">
+
−
We are 2015 NCTU_Formosa!<BR>
+
  
−
Abstract<BR>
+
        video#bgvid{
−
         This year, our project focuses on the diagnoses before and after treatment for cancers. Two systems are constructed for our project. The first system displays scFv on the surface of E.coli while the second one displays gold binding peptide (GBP). <BR>
+
position:relative;
 +
top:80px;
 +
         min-width: 72%;
 +
        min-height: 72%;
 +
        width: 72%;
 +
    height: auto;
 +
margin:0px auto;
 +
padding-left:13vw;
 +
       
 +
}
 +
        .p-2{
 +
    background-image:url("https://static.igem.org/mediawiki/2015/8/8f/Apollo_no_background.png");
 +
    position:relative;
 +
height:90vh;
 +
    width:90%;
 +
background-position:center;
 +
    background-size:50%;
 +
    background-repeat:no-repeat;
 +
    left:3%;
 +
}
 +
.photo3-1{
 +
background-image:url("https://static.igem.org/mediawiki/2015/5/51/2015_NCTU_Formosa_Homepage_21.png");
 +
width:100%;
 +
height:100%;
 +
position:relative;
 +
top:0%;
 +
left:5%;
 +
background-size:90%;
 +
background-repeat:no-repeat;
 +
}
 +
.photocontent1{
 +
color: #000;
 +
font-family:Arial;
 +
font-size: 18px;
 +
text-decoration:none;
 +
text-align: justify;
 +
margin-left : 8%;
 +
width:80%;
 +
}
 +
 +
.photo3-2{
 +
background-image:url("https://static.igem.org/mediawiki/2015/2/2e/NCTU_Formosa_Homepage_antibody.png");
 +
height:100%;
 +
width:100%;
 +
position:relative;
 +
background-size:90%;
 +
background-repeat:no-repeat;
 +
left:4%;
 +
top:0%;
 +
}
  
−
        For the diagnoses before treatment, the first system is utilized. By using the fluorescent E.coli with scFv displayed on the surface, IHC procedure can be simplified because the process of adding secondary antibodies is omitted. Furthermore, the omission can solve the current problem of non-specific binding of secondary antibodies. In addition, the combination of the designed E.coli with the current, fully developed measurement technology can obtain quantitative results.<BR>
+
.photocontent2{
 +
color: #000;
 +
font-family:Arial;
 +
font-size: 18px;
 +
text-decoration:none;
 +
text-align: justify;
 +
position:absolute;
 +
top:50%;
 +
left:8%;
 +
height:50%;
 +
width:80%;
 +
}
 +
.photo3-3{
 +
background-image:url("https://static.igem.org/mediawiki/2015/2/2c/Nctu_formosa_homepage_cell.png");
 +
height:100%;
 +
width:100%;
 +
position:relative;
 +
background-size:50%;
 +
background-repeat:no-repeat;
 +
left:5%;
 +
top:0%;
 +
}
  
−
        A dual system involving E.coli displaying scFv and E.coli displaying GBP can solve a common random orientation problem of antibodies coating on gold chip to attain an accurate measurement. Therefore, the dual system can also offer a quantitative and accurate diagnosis for after treatment of cancer. <BR>
+
.photocontent3{
−
 
+
color: #000;
−
According to the application of the two systems, the project not only improves the diagnoses of the cancer types before treatment easily and rapidly, but also helps track the patient’s condition after treatment by multifaceted measurement technology with more accurate quantitative results! <BR>
+
font-family:Arial;
 +
font-size: 18px;
 +
text-decoration:none;
 +
text-align: justify;
 +
position:absolute;
 +
top:50%;
 +
left:8%;
 +
height:50%;
 +
width:80%;
 +
}
 +
        .p-4{
 +
        background:#FCFCDE;
 +
        height:80vh;
 +
position: relative;
 +
background-image:url(https://static.igem.org/mediawiki/2015/8/8d/NCTU_FORMOSA_HOMEPAGE_ECOTECTOR_nR.png);
 +
background-size:80%;
 +
background-position: center;
 +
background-repeat: no-repeat;
 +
}
 +
.div3 img{
 +
width:85%;
 +
margin-left:7.5%;
 +
}
 +
</style>
 +
  </head>
 +
 
 +
  <body>
  
  
 +
<div class="div1">
 +
<div class="div1-1">
 +
<video autoplay id="bgvid" controls="true">
 +
<source src="https://static.igem.org/mediawiki/2015/0/09/Nctu_formosa_homepage_vide5.mp4" type="video/mp4">
 +
</source>
 +
        </video>
 
</div>
 
</div>
 +
</div>
 +
   
 +
    <div class="div2">
 +
<div class="p-2"></div>
 +
        <div style="position:absolute;bottom:30%;width:100%;text-align:center;font-size:18pt;letter-spacing:5px;">The only thing we can detect is everything.</div>
 +
</div>
 +
   
 +
    <div class="div3 ">
 +
<div class="div3-1">
 +
 +
          <img src="https://static.igem.org/mediawiki/2015/5/51/2015_NCTU_Formosa_Homepage_21.png" align="center" height=250px>
 +
      <div class="photocontent1"><h2>Who we are</h2>
 +
      NCTU_Formosa created an organization—APOllO, which stands for Almighty Probe of scFv Organization. APOllO is devoted to developing detection technology by utilizing antibodies. In 2015, we cooperated with iGEM to create a brand new detection platform using synthetic biology.</div>
 +
    </div>
 +
           
 +
        <div class="div3-2">
 +
    <img src="https://static.igem.org/mediawiki/2015/2/2e/NCTU_Formosa_Homepage_antibody.png" align="middle" height=250px>
 +
      <div class="photocontent1"><h2>What's new</h2>
 +
APOllO E.Cotector:<br> 
 +
Our organization creates a customized scFv detection platform by co-transforming any desired plasmid in to <i>E. coli</i>. ScFv utilizes antigen-antibody interaction to act as probes. Therefore, our E.Cotector has the function of a detector.
 +
      </div> </div>
 +
           
 +
          <div class="div3-3">
 +
    <img src="https://static.igem.org/mediawiki/2015/7/77/Nctu_formosa_homepage_photo3.jpg" align="middle" height=250px>
 +
           
 +
        <div class="photocontent1"><h2>What we care about</h2>
 +
       
 +
In 2015, we focused on helping doctors select appropriate candidates for monoclonal-antibody targeted drug treatments—reducing the price of patients' treatment. If the cost for diagnosis decreases, more patients can afford it. Therefore lowering the mortality rate of cancer. <br>
 +
            </div>
 +
      </div>
 +
</div>
 +
   
 +
        <div class="p-4">
 +
        <div style="position:absolute;bottom:17vh;right:20vw;font-size:20pt;"><a href="https://2015.igem.org/Team:NCTU_Formosa/Project" style="color:#000;"><u>Get Ready to Explore</a></U></div>
 +
        </div>
 +
</div>
  
−
 
+
 
 
</body>
 
</body>
−
</html>
+
</html>{{Team:NCTU_Formosa/footer}}

Latest revision as of 02:41, 19 September 2015

The only thing we can detect is everything.

Who we are

NCTU_Formosa created an organization—APOllO, which stands for Almighty Probe of scFv Organization. APOllO is devoted to developing detection technology by utilizing antibodies. In 2015, we cooperated with iGEM to create a brand new detection platform using synthetic biology.

What's new

APOllO E.Cotector:
Our organization creates a customized scFv detection platform by co-transforming any desired plasmid in to E. coli. ScFv utilizes antigen-antibody interaction to act as probes. Therefore, our E.Cotector has the function of a detector.

What we care about

In 2015, we focused on helping doctors select appropriate candidates for monoclonal-antibody targeted drug treatments—reducing the price of patients' treatment. If the cost for diagnosis decreases, more patients can afford it. Therefore lowering the mortality rate of cancer.